Organon (OGN) Other Non Operating Income (2020 - 2026)

Organon (OGN) recorded quarterly Other Non Operating Income of $96.0 million in Q1 2026, up 243.28% quarter-over-quarter from -$67.0 million in Q4 2025, and up 2300.0% on a YoY basis from $4.0 million in Q1 2025.

Organon (OGN) Other Non Operating Income (2020 - 2026) Analysis & Trends

Organon's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $96.0 million for Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 2300.0% year-over-year to $96.0 million; the TTM figure through Mar 2026 stood at $60.0 million (up 957.14% YoY), while the FY2025 annual figure was -$14.0 million, up 33.33% from the prior year.
  • Other Non Operating Income was $96.0 million for Q1 2026 at Organon, up from -$67.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $96.0 million in Q1 2026 to a low of -$67.0 million in Q4 2025.
  • Historically, Other Non Operating Income has averaged $1.6 million across 5 years, with a median of -$3.0 million in 2022.
  • The sharpest annual moves came in 2022 and 2026: Other Non Operating Income sank 1700.0% in 2022, then soared 2300.0% in 2026.
  • A 5-year view of Other Non Operating Income shows it stood at -$32.0 million in 2022, then jumped by 131.25% to $10.0 million in 2023, then tumbled by 220.0% to -$12.0 million in 2024, then sank by 458.33% to -$67.0 million in 2025, then surged by 243.28% to $96.0 million in 2026.
  • The last three Other Non Operating Income figures came in at $96.0 million (Q1 2026), -$67.0 million (Q4 2025), and $30.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 96.00 Mn
Dec 31, 2025 -67.00 Mn
Sep 30, 2025 30.00 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 4.00 Mn
Dec 31, 2024 -12.00 Mn
Jun 30, 2024 1.00 Mn
Mar 31, 2024 -6.00 Mn
Dec 31, 2023 10.00 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 -6.00 Mn
Dec 31, 2022 -32.00 Mn
Sep 30, 2022 -4.00 Mn
Jun 30, 2022 21.00 Mn
Mar 31, 2022 -4.00 Mn
Dec 31, 2021 2.00 Mn
Sep 30, 2021 -1.00 Mn
Jun 30, 2021 -20.00 Mn
Mar 31, 2021 2.00 Mn